TO STUDY THE EFFECT OF PURGATION IN DADRU KUSHTA(TINEA CORPORIS)

Phase 2/3

Not yet recruiting

Conditions: Other specified local infections of the skin and subcutaneous tissue. Ayurveda Condition: DADRU-KUSHTHAH,

Registration Number: CTRI/2021/10/037030

Lead Sponsor: Self

Brief Summary: This a Randomized Open Labelled Single Armed Clinical study to Assess the efficacy of Virechana Karma in Dadru Kushta(Tinea Corporis).A minimum of 30 subjects will be selected for the study. Assessment will be done on the basis of prepared proforma including subjective and objective parameters with different scales. Kushta is a Raktapradoshaja vyadhi occurring as result of pitta along with rakta and twak adhistana Dadru is commonly recurring skin infection and is anushangi , As Dadru kushta is tridoshaja vyadhi with predominance vitiation of pitta and kapha dosha ,Hence this study is planned to explore the role of Virechana Karma in Dadru Kushta (tinea corporis).

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 30

Inclusion Criteria

1.Subjects representing lakshana of dadru kushta 2.Subjects of age group 15-65yrs 3.Subjects fit for virechana 4.Subjects willing to sign consent form.

Exclusion Criteria

1.Subjects suffering from any chronic illness and other metabolic disorders 2.Subjects suffering from HIV/HBsAG/VDRL/STDs will be excluded 3.Pregnant and lactating women 4.Other skin manifestations.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment of Virechana karma On Dadru Kushta Lakshana(SUBJECTIVE AND OBJECTIVE PARAMETERS)	At the end of 21 Days(total time duration)
SUBJECTIVE PARAMETERS:	At the end of 21 Days(total time duration)
KANDU	At the end of 21 Days(total time duration)
RUKSHATA	At the end of 21 Days(total time duration)
PIDAKA	At the end of 21 Days(total time duration)
RAGA	At the end of 21 Days(total time duration)
OBJECTIVE PARAMETERS:	At the end of 21 Days(total time duration)
MANDALA	At the end of 21 Days(total time duration)

Secondary Outcome Measures

Name	Time	Method
Hb%	T.L.C

Trial Locations

Locations (1): SIDRAMAPPA DANIGOND MEMORIAL TRUSTS AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE
🇮🇳
Bagalkot, KARNATAKA, India
SIDRAMAPPA DANIGOND MEMORIAL TRUSTS AYURVEDIC MEDICAL COLLEGE AND RESEARCH CENTRE
🇮🇳Bagalkot, KARNATAKA, India
DR M NISARGA
Principal investigator
8660592157
mnisargam@gmail.com